Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

The colchicine debacle.

Guglielmo BJ.

JAMA Intern Med. 2013 Feb 11;173(3):184-5. doi: 10.1001/jamainternmed.2013.1405. No abstract available.

PMID:
23277277
2.

Colchicine.

Redberg RF.

JAMA Intern Med. 2013 Feb 11;173(3):185. doi: 10.1001/jamainternmed.2013.3093. No abstract available.

PMID:
23277365
3.

Nonsteroidal anti-inflammatory drugs and colchicine to prevent gout flare during early urate-lowering therapy: perspectives on alternative therapies and costs.

Peterson DM.

J Pain Palliat Care Pharmacother. 2010 Dec;24(4):402-4. doi: 10.3109/15360288.2010.526174.

PMID:
21133751
4.

A new perspective on the pharmacoeconomics of colchicine.

Wertheimer AI, Davis MW, Lauterio TJ.

Curr Med Res Opin. 2011 May;27(5):931-7. doi: 10.1185/03007995.2011.563284. Epub 2011 Mar 3. Review.

PMID:
21370937
5.

Colchicine: time to rethink.

Varughese GI, Varghese AI, Tahrani AA.

N Z Med J. 2007 Feb 16;120(1249):U2429. No abstract available.

PMID:
17308565
6.

Prevention of colchicine toxicity in patients with gout.

Dalbeth N, Gow P.

N Z Med J. 2007 Apr 13;120(1252):U2503. No abstract available.

PMID:
17460750
7.

Colchicine: caution!

[No authors listed]

Prescrire Int. 2011 Mar;20(114):70. No abstract available.

PMID:
21649967
8.

Colchicine in acute gout.

Morris I, Varughese G, Mattingly P.

BMJ. 2003 Nov 29;327(7426):1275-6. No abstract available.

9.

Fixed drug eruption due to colchicine.

Mochida K, Teramae H, Hamada T.

Dermatology. 1996;192(1):61.

PMID:
8832955
10.

Use of intravenous colchicine in patients with acute gout.

Stephan WH.

Am Fam Physician. 2000 Apr 15;61(8):2343-4. No abstract available.

11.

Promoting the safe use of intravenous colchicine.

Tortorici MA, Skledar S, Barnes B, Wasko MC.

Am J Health Syst Pharm. 2004 Dec 1;61(23):2496, 2501. No abstract available.

PMID:
15595222
12.

Hazards of colchicine.

Jones WN, Maricic MJ.

Am J Health Syst Pharm. 2005 Jul 1;62(13):1350; author reply 1350. No abstract available.

PMID:
15972374
13.

Colchicine for the treatment of gout.

Richette P, Bardin T.

Expert Opin Pharmacother. 2010 Dec;11(17):2933-8. doi: 10.1517/14656566.2010.529432. Review.

PMID:
21050036
14.

[Skin reaction from colchicine].

Vittori F, Liautard C, Riou V.

Therapie. 2001 Jan-Feb;56(1):63-5. French. No abstract available.

PMID:
11322022
15.

Fatal colchicine toxicity.

Kubler PA.

Med J Aust. 2000 May 15;172(10):498-9. No abstract available.

PMID:
10901774
16.

Incentives for drug developmentā€”the curious case of colchicine.

Woodcock J, Okada S.

N Engl J Med. 2010 Oct 7;363(15):1484; author reply 1484-5. doi: 10.1056/NEJMc1007963. No abstract available.

17.

Colchicine prescribing in patients with gout.

Dalbeth N, Gow P; New Zealand Rheumatology Association.

N Z Med J. 2011 Jul 29;124(1339):107-8. No abstract available.

PMID:
21952339
18.

Colchicine induced rhabdomyolysis.

Chattopadhyay I, Shetty HG, Routledge PA, Jeffery J.

Postgrad Med J. 2001 Mar;77(905):191-2.

19.

Colchicine myopathy.

Tapal MF.

Scand J Rheumatol. 1996;25(2):105-6.

PMID:
8614764
20.

Dangers of low-dose colchicine in patients with renal failure.

[No authors listed]

Prescrire Int. 2000 Aug;9(48):116.

PMID:
11067723

Supplemental Content

Support Center